Studies on the Metabolic Fate of Mometasone furoate(MF). (III). Transfer into the Fetus and Milk.
スポンサーリンク
概要
- 論文の詳細を見る
Foeto-placental transfer and excretion into the milk of radioactivity was studied following subcutaneous administration of <SUP>14</SUP>C-MF to pregnant or lactating rats at the dose of 0.5mg/kg.<BR>1. On day 13 of gestation, no radioactivity was detected in the fetus based on the whole-body autoradiography.<BR>2. On day 19 of gestation, the highest level of radioactivity, found within the fetus, was observed in the intestinal contents, and almost similar levels as that of mother plasma were observed in the liver and lung as determined by theradioactivity measurement and wholebody autoradiography.<BR>3. Radioactivity level in the milk was nearly two-fold higher than that of plasma at 4hr after administration but it disappeared below detection limit at 72 hr after administration.
- 日本薬物動態学会の論文
日本薬物動態学会 | 論文
- COMPETITIVE DISPLACEMENT OF SERUM PROTEIN BINDING TO REGULATE PHARMACOKINETICS OF A CEREBRAL BLOOD FLOW RADIOPHARMACEUTICAL
- Studies on the Metabolic Fate of Felodipine. (IV). Identification of New Metabolites of Felodipine in Rat.
- Metabolic Fate of Pergolide Mesylate. (2): Absorption, Distribution, Excretion of 14C-Pergolide Mesylate in Rats after Repeated Administration.
- Studies on the Metabolic Fate of 3H-TJN-101. (III): Absorption, Distribution and Excretion after Multiple Oral Administration to Rats.
- Studies on the Pharmacokinetics of Perindopril Erbumine in Rats. (1): Plasma Level Profile, Distribution, Metabolism and Excretion after Single Oral Administration.